REVELATION BIOSCIENCES, INC. - REVB
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q4 2025
· Q3 2025
Value (USD)
Total reported value ($000)
$981K
QoQ value delta ($000)
+$445K
(+83.02%)
Implied price effect (QoQ)
-43.49%
Shares
Total shares
1,231,042
QoQ shares delta
+850,945
(+223.88%)
Total shares held by funds (by quarter)
Market chart (REVB)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q4 2025)
Top 25 only
Full list
Early Q2 2026 data: only 13 institutional holders reported so far. More will appear as funds file with the SEC.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 484 | 605,702 | 0.7% |
| ARMISTICE CAPITAL, LLC | 347 | 434,272 | 0.0% |
| CITADEL ADVISORS LLC | 43 | 54,728 | 0.0% |
| VANGUARD GROUP INC | 42 | 52,505 | 0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 27 | 34,019 | 0.0% |
| NORTHERN TRUST CORP | 17 | 21,907 | 0.0% |
| HRT FINANCIAL LP | 12 | 15,320 | 0.0% |
| XTX Topco Ltd | 9 | 11,319 | 0.0% |
| BANK OF AMERICA CORP /DE/ | 0 | 47 | 0.0% |
| DANSKE BANK A/S | 0 | 1 | 0.0% |
| ROYAL BANK OF CANADA | 0 | 2 | 0.0% |
| BNP Paribas Asset Management Holding S.A. | 0 | 38 | 0.0% |
| UBS Group AG | 0 | 724 | 0.0% |
| SBI Securities Co., Ltd. | 0 | 458 | 0.0% |